Catalyst Biosciences, Inc. Profile Avatar - Palmy Investing

Catalyst Biosciences, Inc.

Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecul…

Biotechnology
US, South San Francisco [HQ]
Revenue Breakdowns

Segment Analysis Beta

The financial segments are sourced from the SEC' 10-K statement.

Revenue By Top Segments

Catalyst Biosciences, Inc. can't present it's sankey chart.

Historical Revenue By Segment

Last 3Y, in million USD

Catalyst Biosciences, Inc. can't present revenue by segment

Get PRO Today

With PRO you can bypass the blur for the segment revenues of Catalyst Biosciences, Inc..

If you want to see a demo, head over to the financial segments of AAPL

End of CBIO's Analysis
CIK: 1124105 CUSIP: 14888D208 ISIN: US4037831033 LEI: - UEI: -
Secondary Listings
CBIO has no secondary listings inside our databases.